Allergy Therapeutics Plc Stock Price Prediction
| AGYTF Stock | USD 0.11 0.00 0.00% |
Momentum 100
Buy Peaked
Oversold | Overbought |
Using Allergy Therapeutics hype-based prediction, you can estimate the value of Allergy Therapeutics plc from the perspective of Allergy Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Allergy Therapeutics to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Allergy because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Allergy Therapeutics after-hype prediction price | USD 0.08 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Allergy |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Allergy Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Allergy Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Allergy Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Allergy Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Allergy Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Allergy Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Allergy Therapeutics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Allergy Therapeutics' historical news coverage. Allergy Therapeutics' after-hype downside and upside margins for the prediction period are 0.00 and 2.94, respectively. We have considered Allergy Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Allergy Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Allergy Therapeutics plc is based on 3 months time horizon.
Allergy Therapeutics Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Allergy Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Allergy Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Allergy Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.44 | 2.86 | 0.03 | 0.60 | 10 Events / Month | 2 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.11 | 0.08 | 27.27 |
|
Allergy Therapeutics Hype Timeline
Allergy Therapeutics plc is presently traded for 0.11. The entity has historical hype elasticity of -0.03, and average elasticity to hype of competition of 0.6. Allergy is anticipated to decline in value after the next headline, with the price expected to drop to 0.08. The average volatility of media hype impact on the company price is over 100%. The price reduction on the next news is expected to be -27.27%, whereas the daily expected return is presently at 0.44%. The volatility of related hype on Allergy Therapeutics is about 210.29%, with the expected price after the next announcement by competition of 0.71. About 84.0% of the company shares are held by company insiders. The book value of Allergy Therapeutics was presently reported as 0.06. The company recorded a loss per share of 0.01. Allergy Therapeutics plc had not issued any dividends in recent years. Assuming the 90 days horizon the next anticipated press release will be in about 10 days. Check out Allergy Therapeutics Basic Forecasting Models to cross-verify your projections.Allergy Therapeutics Related Hype Analysis
Having access to credible news sources related to Allergy Therapeutics' direct competition is more important than ever and may enhance your ability to predict Allergy Therapeutics' future price movements. Getting to know how Allergy Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Allergy Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MTLHF | Mitsubishi Chemical Holdings | 0.00 | 0 per month | 1.87 | 0 | 3.80 | (4.73) | 18.11 | |
| PKE | Park Electrochemical | (0.37) | 7 per month | 1.94 | (0) | 3.76 | (3.64) | 12.38 | |
| CRM | Salesforce | 2.25 | 7 per month | 0.00 | (0.07) | 3.22 | (3.61) | 9.91 | |
| KBDCY | Kingboard Chemical Holdings | 7.64 | 12 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| GDQMF | GoldQuest Mining Corp | 0.00 | 0 per month | 3.04 | 0.23 | 8.70 | (6.12) | 29.37 | |
| FREDF | Fredonia Mining | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ZZHGY | ZhongAn Online P | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Allergy Therapeutics Additional Predictive Modules
Most predictive techniques to examine Allergy price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Allergy using various technical indicators. When you analyze Allergy charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Absolute Price Oscillator | ||
| Plus Directional Indicator | ||
| Stochastic | ||
| Momentum | ||
| Aroon | ||
| Ultimate Oscillator | ||
| MACD with controllable MA type | ||
| Rate of change ratio | ||
| Chande Momentum Oscillator | ||
| Balance Of Power |
About Allergy Therapeutics Predictive Indicators
The successful prediction of Allergy Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Allergy Therapeutics plc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Allergy Therapeutics based on analysis of Allergy Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Allergy Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Allergy Therapeutics's related companies.
Story Coverage note for Allergy Therapeutics
The number of cover stories for Allergy Therapeutics depends on current market conditions and Allergy Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Allergy Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Allergy Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Allergy Therapeutics Short Properties
Allergy Therapeutics' future price predictability will typically decrease when Allergy Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Allergy Therapeutics plc often depends not only on the future outlook of the potential Allergy Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Allergy Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 644.1 M | |
| Short Long Term Debt | 952 K | |
| Shares Float | 115.8 M |
Complementary Tools for Allergy Pink Sheet analysis
When running Allergy Therapeutics' price analysis, check to measure Allergy Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allergy Therapeutics is operating at the current time. Most of Allergy Therapeutics' value examination focuses on studying past and present price action to predict the probability of Allergy Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allergy Therapeutics' price. Additionally, you may evaluate how the addition of Allergy Therapeutics to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |